Literature DB >> 2093469

The facile detection of the nt 1226 mutation of glucocerebrosidase by 'mismatched' PCR.

E Beutler1, T Gelbart, C West.   

Abstract

The most common Gaucher disease-producing mutation among Ashkenazi Jews is an A----G substitution at cDNA nt 1226 (genomic nt 5841). We describe a simple method for detecting this mutation both in genomic DNA and in cDNA by performing polymerase chain reaction (PCR) using a 5'-primer mismatched at one nucleotide so as to create an Xho I restriction site. When the mutation is present. the 105 bp fragment formed is cleaved to 89 and 16 nt fragments. The 89 bp fragment is easily visualized on a gel making it possible to distinguish individuals who do not have the mutation from heterozygotes and homozygotes.

Mesh:

Substances:

Year:  1990        PMID: 2093469     DOI: 10.1016/0009-8981(90)90130-k

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  11 in total

1.  Familial hypercholesterolemia associated with severe hypoalphalipoproteinemia in a Moroccan family.

Authors:  Karima Ait Chihab; Rachif Chater; Ana Cenarro; Anass Kettani; Sergio Castillo; Mohamed Loutfi; Josep Ribalta; Ahmed Adlouni; Miguel Pocovi; Mariame El Messal
Journal:  J Genet       Date:  2007-08       Impact factor: 1.166

2.  High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews.

Authors:  A Zimran; T Gelbart; B Westwood; G A Grabowski; E Beutler
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

Review 3.  The glucocerebrosidase locus in Gaucher's disease: molecular analysis of a lysosomal enzyme.

Authors:  P K Mistry; T M Cox
Journal:  J Med Genet       Date:  1993-11       Impact factor: 6.318

4.  The N370S mutation in the glucocerebrosidase gene of Portuguese type 1 Gaucher patients: linkage to the PvuII polymorphism.

Authors:  L Lacerda; O Amaral; R Pinto; J Aerts; M C Sá Miranda
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

5.  Dynamic changes of lipid profile in Romanian patients with Gaucher disease type 1 under enzyme replacement therapy: a prospective study.

Authors:  Anca Zimmermann; Paula Grigorescu-Sido; Heidi Rossmann; Karl J Lackner; Cristina Drugan; Camelia Al Khzouz; Simona Bucerzan; Ioana Naşcu; Tim Zimmermann; Daniel Leucuţa; Matthias M Weber
Journal:  J Inherit Metab Dis       Date:  2012-09-14       Impact factor: 4.982

6.  Outcome of enzyme replacement therapy in patients with Gaucher disease type I. The Romanian experience.

Authors:  P Grigorescu Sido; C Drugan; V Cret; C Al-Kzouz; C Denes; C Coldea; A Zimmermann
Journal:  J Inherit Metab Dis       Date:  2007-08-20       Impact factor: 4.982

7.  Characterization of glucocerebrosidase in Greek Gaucher disease patients: mutation analysis and biochemical studies.

Authors:  H Michelakakis; E Dimitriou; S Van Weely; R G Boot; I Mavridou; M Verhoek; J M Aerts
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

8.  Molecular characterisation of type 1 Gaucher disease families and patients: intrafamilial heterogeneity at the clinical level.

Authors:  O Amaral; A M Fortuna; L Lacerda; R Pinto; M C Sa Miranda
Journal:  J Med Genet       Date:  1994-05       Impact factor: 6.318

9.  Phenotype/genotype correlations in Gaucher disease type I: clinical and therapeutic implications.

Authors:  A Sibille; C M Eng; S J Kim; G Pastores; G A Grabowski
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

10.  Identification of the second common Jewish Gaucher disease mutation makes possible population-based screening for the heterozygous state.

Authors:  E Beutler; T Gelbart; W Kuhl; J Sorge; C West
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.